EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study)

Gaelle Kramer, José Volders, Femke den Haring, Roza Opperman, Pauline Spronk, Petrousjka van den Tol, Marie-Jeanne Vrancken Peeters, Snapshot Breast Cancer Collaborative Study Group

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2025.10.019 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Gaelle Kramer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Mastectomy, Mastectomy, Segmental. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The use of neoadjuvant systemic therapy (NST) in primary breast cancer has increased worldwide. This study provides real-time data of the reasons and variation in NST, conversion rate of mastectomy to BCS and conversion rate of ALND to radiation or omission of axillary treatment. METHODS: This is a Breast Cancer Surgery Snapshot study, multicenter prospective cross-sectional study in 70 breast cancer hospitals in the Netherlands. For 2 months the reason for NST is registered with patient- and tumor characteristics. The expectation of the surgical procedure in breast and axilla before and after NST is noted and the actual surgical outcome after NST is registered. RESULTS: Four hundred sixty seven patients receiving NST were registered. The 3 main reasons for NST were in 26% axillary down-staging, 25% a triple negative (TN) tumor and 25% HER2+. Before NST, 219 patients (47%) were eligible for BCS. In 210 patients (45%) initially assigned to receive a mastectomy, 99 patients (47%) underwent BCS. Triple negativity had the highest conversion rate with 68%. Of all mastectomy patients, 30% showed a pCR of the breast. Axillary conversion from ALND to axillary sparing surgery was achieved in 87% cN+ patients. CONCLUSION: In the Netherlands the main reasons for NST were subtype (triple negative, HER2+) and axillary down staging. Additional reasons for NST focused more on down staging to convert to BCS and improve cosmetic outcomes. Real time data showed that NST lead to very high conversion rates from mastectomy to BCS as well as high rates of omission of ALND after NST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsMastectomyMastectomy, SegmentalHumansFemaleMiddle AgedCross-Sectional StudiesProspective StudiesNetherlandsAgedAdultAxillaLymph Node ExcisionTriple Negative Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Breast surgery after NSTConversion from mastectomy to NCS after NSTOmission of ALND after NST

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Surgical Oncology, Diakonessenhuis, Utrecht, The Netherlands.
  • Department of Surgical Oncology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
  • Department of Surgical Oncology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Surgical Oncology, Alrijne Ziekenhuis, Leiden, The Netherlands.
  • Department of Surgical Oncology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.

Zitieren

APA

Kramer, G., Volders, J., den Haring, F., Opperman, R., Spronk, P., Tol, P. V. D., Vrancken Peeters, M. J., & Snapshot Breast Cancer Collaborative Study Group (2026). National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study). Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.10.019

Vancouver

Kramer G, Volders J, den Haring F, Opperman R, Spronk P, Tol PVD, et al. National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study). Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.10.019

BibTeX
@article{Kramer2026,
  author = {Kramer, Gaelle and Volders, José and den Haring, Femke and Opperman, Roza and Spronk, Pauline and Tol, Petrousjka van den and Vrancken Peeters, Marie-Jeanne and Snapshot Breast Cancer Collaborative Study Group, Snapshot Breast Cancer Collaborative Study Group},
  title = {National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study)},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2025.10.019}
}
Kostenlos starten →